68Ga-AAZTA-NI-093 PET/CT: First-in-human Study
NCT06612580
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer (Adenocarcinoma)
Interventions
DRUG:
68Ga-AAZTA-NI-093
Sponsor
First Affiliated Hospital of Fujian Medical University